Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Look among the millions of people with multiple sclerosis and you'll find famous faces, too. Learn how some of these celebrities are dealing with MS and raising awareness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results